7th Annual Basser Global Prize Awarded to Cambridge Professors Douglas Easton and Antonis Antoniou

We're pleased to announce Douglas Easton, PhD, and Antonis Antoniou, PhD, as the recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre.
Their research focuses on genetic susceptibility to common cancers with the goal of identifying and characterizing genetic variants associated with cancer risk, with a particular emphasis on hormone-related cancers. Much of their work has focused on characterizing the cancer risks for BRCA1 and BRCA2 mutation carriers.

Shannon Pulaski: Preventative Care and the Power of Support

Pictured above (right) with her sister, Shannon Pulaski, author and member of the Basser Young Leadership Council, discusses the anxiety often experienced by BRCA mutation carriers and the importance of support in this essay for the Basser blog.
“The building looks like a large corporate office complex, not like a hospital. I hesitate, half hoping that I am in the wrong place. Until the sign stares me in the face, and I can’t unsee it. 'Cancer Center.' I don’t have cancer, but here I am. This is my life. This is my reality. I am BRCA positive.”

Ann Steiner, MD: What You Need to Know About Surgical Menopause

Ann L. Steiner, MD, an obstetrician-gynecologist and clinical professor at Penn Medicine, discusses surgical menopause, including what to expect and how to best prepare - important information for BRCA carriers preparing to undergo a preventative oophorectomy to eliminate risk of hereditary ovarian cancer. 

Ronny Drapkin, MD, PhD, Reviews Advances in Ovarian Cancer Treatment Research

This September, for Ovarian Cancer Awareness Month, Basser's Director of Gynecologic Cancer Research Ronny Drapkin, MD, PhD, discusses the latest in ovarian cancer research. 

Basser Center Research Round-Up

Dr. Domchek on Potential Benefits of Biosimilars in Oncology
Susan Domchek, MD, Executive Director of the Basser Center, discusses the potential benefits of biosimilars in oncology. Biosimilars are like "generic" medications; they are officially approved versions of innovative, original products.

Analyzing Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer
Targeted Oncology interviews Penn Medicine's Angela DeMichele, MD, MSCE, a past Basser funded scientist, about factors that predict responses to neoadjuvant chemotherapy in various subgroups of patients with breast cancer.

The Basser Center is proud to host, sponsor, and participate in events throughout the country.
October 3, 2019
October 5, 2019
Ride for Research Spin-a-thon Fundraiser
(Philadelphia, PA, New York, NY, and Milburn, NJ.)
October 28, 2019
UJA-Federation of New York's The BRCA Gene: Let's Talk About It panel with 
Basser Executive Director Susan Domchek, MD (New York, NY)
November 5, 2019
November 18, 2019
Basser Jean Bash (New York, NY)
Basser Center
Facebook Twitter Instagram | 215.662.2748
Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.
This email was sent to
Continue receiving our emails, add us to your address book.